MAIA Biotechnology
disease control rate as primary in trials one | MAIA Biotechnology
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
14 of 31
Related slides by other companies
Chimerix
Investor Conference
November 2021
overall response rate | Chimerix
BioAtla
Investor Presentation
January 2024
potential market opportunity in metastatic pause available treatment | BioAtla
Theravance Biopharma
Investor Conference
November 2022
study design | Theravance Biopharma
Theravance Biopharma
Investor Conference
November 2022
| Theravance Biopharma
Other recent decks by MAIA Biotechnology
See all presentations (4 decks)
Investor Presentation
November 2023
Investor Presentation
October 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io